Dr. Minor is Associate Director of the California Pacific Medical Center for Melanoma
Research and Treatment, an integrated basic and clinical research program dedicated
to developing novel therapies for both cutaneous and ocular melanoma. Dr. Minor collaborates
closely with Drs. Mohammed Kashani-Sabet and Stanley Leong on multiple research projects.
Dr. Minor leads many clinical trials of immunotherapy and targeted therapies for advanced
and metastatic disease, studies prognostic factors in metastatic melanoma patients
treated with biochemotherapy and immunotherapy, and investigates other aspects of
the biology and genetics of melanoma. He has authored nearly 50 publications,
many on the immunotherapy of metastatic melanoma.
Sutter Health Research Enterprise
2100 Webster St., Suite 326
San Francisco, CA, 94115
(415) 885-8600
minord@sutterhealth.org
Primary Research Interests
Related Clinical Trials
Uveal Melanoma (Sirspheres Uveal)
Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
Investigators: Kevin Kim MD, David Minor M.D.
Status: Active, Recruiting